ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 272 filers reported holding ICU MED INC in Q3 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,167 | -49.6% | 18,215 | -30.1% | 0.02% | -57.7% |
| Q1 2023 | $4,301 | +228.6% | 26,077 | +213.6% | 0.05% | +173.7% |
| Q4 2022 | $1,309 | -99.8% | 8,315 | +236.2% | 0.02% | +375.0% |
| Q1 2022 | $550,000 | -31.3% | 2,473 | -26.8% | 0.00% | -20.0% |
| Q4 2021 | $801,000 | -40.8% | 3,378 | -41.7% | 0.01% | -37.5% |
| Q3 2021 | $1,352,000 | +10.7% | 5,795 | -2.4% | 0.01% | -27.3% |
| Q2 2021 | $1,221,000 | +1.7% | 5,935 | +1.5% | 0.01% | -8.3% |
| Q1 2021 | $1,201,000 | +322.9% | 5,848 | +341.4% | 0.01% | +100.0% |
| Q4 2020 | $284,000 | +8.0% | 1,325 | -5.8% | 0.01% | -45.5% |
| Q4 2019 | $263,000 | +24.6% | 1,406 | +52.7% | 0.01% | -63.3% |
| Q4 2018 | $211,000 | -29.2% | 921 | -12.8% | 0.03% | -34.8% |
| Q3 2018 | $298,000 | – | 1,056 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |